ZIPLINE70 Trademark

Trademark Overview


On Thursday, March 28, 2024, a trademark application was filed for ZIPLINE70 with the United States Patent and Trademark Office. The USPTO has given the ZIPLINE70 trademark a serial number of 98473811. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, October 15, 2024. This trademark is owned by Perfuze Limited. The ZIPLINE70 trademark is filed in the Medical Instrument Products category with the following description:

Catheters for use in neurovascular access
zipline70

General Information


Serial Number98473811
Word MarkZIPLINE70
Filing DateThursday, March 28, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkZIP LINE SEVEN ZERO
Pseudo MarkZIP LINE SEVENTY
Goods and ServicesCatheters for use in neurovascular access

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 28, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePerfuze Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGalway H91W7CP
IE

Trademark Events


Event DateEvent Description
Thursday, March 28, 2024NEW APPLICATION ENTERED
Tuesday, October 8, 2024ASSIGNED TO EXAMINER
Friday, August 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 7, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, January 7, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, October 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 15, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 15, 2024NON-FINAL ACTION WRITTEN